Effects of Post Isometric Relaxation and Janda's Approach in Patient With Shoudler Girdle Crossed Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of treatments—Post Isometric Relaxation and Janda’s Approach—to help people with Upper Crossed Syndrome, a condition where certain muscles around the neck and shoulders become tight and others become weak. This muscle imbalance can cause pain and discomfort in the neck and shoulder area. The Janda Approach focuses on restoring muscle balance by relaxing tight muscles, strengthening weak ones, and improving muscle endurance to support better posture and reduce pain.
Adults between 18 and 50 years old who experience neck pain triggered by certain neck movements or positions may be eligible to join the study. However, people with specific conditions like nerve problems in the neck (cervical radiculopathy), past neck or spine injuries, surgeries, or dizziness related to neck pain would not qualify. Participants can expect to receive treatment aimed at improving muscle balance and reducing discomfort. This study has not started recruiting yet, but it aims to find better ways to help those with this common neck and shoulder problem.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group between 18 and 50 years (defined as pain in the area of the neck could be provoked by mechanical characteristics, including sustained neck postures, cervical movement, or manual palpation of the cervical musculature)
- Exclusion Criteria:
- • Cervical radiculopathy
- • History of whiplash injury
- • History of cervical and thoracic spine surgery
- • Neck pain associated with vertigo
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Samrood Akram, PhD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported